These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 8210205)

  • 1. [Vaccination against the enterobacteria responsible for enteric infections].
    Sansonetti PJ
    Ann Gastroenterol Hepatol (Paris); 1994; 30(2):60-3. PubMed ID: 8210205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vaccination against the enterobacteriaceae responsible for enteric infections].
    Sansonetti PJ
    Bull Acad Natl Med; 1993 Nov; 177(8):1401-7; discussion 1407-8. PubMed ID: 8193944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral vaccination against enteric bacterial infections: an overview.
    Germanier R
    Behring Inst Mitt; 1984 Nov; (76):98-105. PubMed ID: 6395852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New vaccines against bacterial enteric infections.
    Holmgren J; Svennerholm AM
    Scand J Infect Dis Suppl; 1990; 70():149-56. PubMed ID: 2287897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An oral enteritis-vaccine composed of twelve heat inactivated Enterobacteriaceae. 1. Communication: Theoretical and epidemiological considerations (author's transl)].
    Raettig H
    Zentralbl Bakteriol Orig A; 1979; 245(3):287-300. PubMed ID: 44783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future vaccines against enteric pathogens.
    Levine MM; Edelman R
    Infect Dis Clin North Am; 1990 Mar; 4(1):105-21. PubMed ID: 2155260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against diarrheal diseases and typhoid fever. Current status and prospects].
    Ivanoff B; Neira M
    Ann Med Interne (Paris); 1998 Oct; 149(6):340-50. PubMed ID: 9853044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An oral enteritis-vaccine composed of twelve heat-inactivated Enterobacteriaceae 3. Communication: studies on efficacy tests in mice protection tests (author's transl)].
    Raettig H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):511-20. PubMed ID: 7036591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral vaccines for preventing intestinal infections (literature review)].
    Kheĭfets LB
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Mar; 51(3):21-8. PubMed ID: 4208437
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenicity testing of inactivated oral enteric bacterial vaccines for human use.
    Joó I
    Dev Biol Stand; 1976; 33():75-9. PubMed ID: 782974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of a typhoid-dysentery bivalent strain with typhoid ty21a and dysentery T32-Istrati strains].
    Chen QY; Jiang LJ; Kong DC; Wang BR
    Wei Sheng Wu Xue Bao; 1987 Dec; 27(4):362-8. PubMed ID: 3329424
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacterial enteric infections and vaccine development.
    Holmgren J; Svennerholm AM
    Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.
    Walker RI
    Vaccine; 2005 May; 23(26):3369-85. PubMed ID: 15837361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccines inf the prevention of fecal hazards].
    Saliou P
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):445-9. PubMed ID: 10078383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
    Phalipon A; Sansonetti P
    Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of immunization against bacterial enteric infections (author's transl)].
    Rey M
    Med Trop (Mars); 1979; 39(4):457-62. PubMed ID: 537492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
    Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
    Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
    [No Abstract]   [Full Text] [Related]  

  • 20. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
    Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM
    Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.